학술논문
Anti-Ro52 antibody is highly prevalent and a marker of better prognosis in patients with ovarian cancer
Document Type
Article
Author
Source
In Clinica Chimica Acta October 2021 521:199-205
Subject
Language
ISSN
0009-8981